| |
Particulars |
Quarter ended 30.09.2006 (Unaudited) |
Quarter ended 30.09.2005 (Unaudited) |
Half Year ended 30.09.2006 (Unaudited) |
Half Year ended 30.09.2005 (Unaudited) |
Year ended 31.03.2006 (Audited) |
| 1 |
Income from Operations |
3419.98 |
2813.01 |
6562.13 |
5045.07 |
11555.23 |
| 2 |
Other income |
2.57 |
67.15 |
2.57 |
129.49 |
334.13 |
| |
Total |
3422.55 |
2880.16 |
6564.70 |
5174.56 |
11889.36 |
| 3 |
Total Expenditure |
3011.10 |
2489.19 |
5784.17 |
4423.33 |
10366.23 |
| |
a) (Increase) / Decrease in stock-in-trade |
(33.23) |
(159.42) |
(118.29) |
(139.27) |
(66.58) |
| |
b) Consumption of Raw materials |
2229.88 |
1987.85 |
4300.12 |
3201.70 |
7447.16 |
| |
c) Staff Cost |
338.23 |
288.79 |
683.46 |
593.83 |
1263.32 |
| |
d) Other Expenditure |
476.22 |
371.97 |
918.88 |
767.07 |
1722.33 |
| |
Operating Profit/ (Loss) |
411.45 |
390.97 |
780.53 |
751.23 |
1523.13 |
| 4 |
Interest |
67.00 |
26.67 |
72.71 |
47.94 |
60.49 |
| 5 |
Depreciation and Amortisation |
1229.46 |
1229.23 |
2458.92 |
2458.47 |
4917.98 |
| 6 |
Profit / (Loss) before Tax |
(885.01) |
(864.93) |
(1751.10) |
(1755.18) |
(3455.34) |
| 7 |
Provision for FBT |
0.13 |
(3.83) |
2.02 |
0.00 |
14.68 |
| 8 |
Provision for Current tax |
- |
- |
- |
- |
(56.09) |
| 9 |
Provision for Deferred Tax |
- |
(291.14) |
- |
(610.14) |
0.00 |
| 10 |
Net Profit /(Loss) |
(885.14) |
(569.96) |
(1753.12) |
(1145.04) |
(3413.93) |
| 11 |
Paid-up equity share capital |
4220.80 |
3020.80 |
4220.80 |
3200.80 |
4220.80 |
| 12 |
Reserves excluding revaluation reserves |
|
|
|
|
21295.76 |
| 13 |
Earning Per Share - FV Rs. 2/- (in Rs.) - |
|
|
|
|
|
| |
Basic |
(0.42) |
(0.39) |
(0.83) |
(0.71) |
(2.04) |
| |
Diluted |
(0.42) |
(0.30) |
(0.83) |
(0.54) |
(2.04) |
| 14 |
Aggregate of Non-Promoter Shareholding |
|
|
|
|
|
| |
Number of Shares |
140708412 |
140708412 |
140708412 |
140708412 |
140708412 |
| |
Percentage of shareholding |
66.67% |
87.92% |
66.67% |
87.92% |
66.67% |
| |
|
|
|
|
|
|
Notes:
- The above results were reviewed by the Audit Committee and subsequently have been taken on record by the Board of Directors in its meeting held on 30th October 2006 and are subject to limited review by the statutory auditors.
- The Company is exclusively engaged in the Pharmaceutical Business segment. Capital employed as on 30th September 2006 is Rs.1,14,029.13 Lacs.
- During the quarter Corporate Restrcturing Cell (CDR) has approved the debt restructuring scheme of the company vide its letter dated 27th July 2006. In fulfillment of one of the conditions the promoter group has brought in Rs. 1,000.00 Lacs. Pursuant to the approval of CDR proposal of the company by CDR Cell, individual sanctions of the Lender Banks have been received in most of the cases.
- 1,000 Naked Warrants have been issued to promoter group.With each naked warrant a right is attached to subscribe to 1,00,000 (One Lac) equity shares at Rs. 10/- per share( face value of Rs. 2/- each at a premium of Rs. 8/- per share) as against price of Rs. 7.90 determined as per SEBI Preferential Issue Guidelines.
- Subject to the approval of Hon'ble High Court at Shimla, The Board considered and finalised ammendments to the scheme u/s 391 of the Companies Act, 1956 for settlement with Fixed Deposit Holders . Meanwhile, interest on fixed deposits for the quarter amounting to Rs.284.71 lacs has not been provided for.
- During the Quarter, 4 shareholders' complaint were received, which were resolved.
- The comparative figures are regrouped and reclassified, wherever considered necessary.
|
| |
For Morepen Laboratories Limited |
Place: New Delhi
Date: 30.10.2006 |
(Sushil Suri)
Chairman & Managing Director |
